Net sales are estimated to be between $14.4 million and $14.8 million with an anticipated EBITDA between $2.7 million and $3.4 million for the three months ended September 30, 2008. Additionally, the Company expects net income per share of $0.01 or less for the three months ended September 30, 2008. These estimated results are based on the Company’s preliminary review of its operations for the quarter, may be subject to further quarter-end adjustments and have not yet been reviewed by its independent registered public accounting firm.
The Company will release final financial results and host an investor conference call on October 30, 2008, following review by its independent registered public accountants.
Merge Healthcare’s solutions solve mission-critical issues for radiology practices, outpatient imaging centers, hospitals, pharmaceutical companies and device manufacturers worldwide.
For additional information, visit www.merge.com
Investor Contact:
Steven M. Oreskovich
Chief Financial Officer
414.977.4000
ir@mergehealthcare.com
